In this double-blind , placebo-controlled trial , @ asymptomatic Plasmodium falciparum parasite carriers were randomized to receive artemether-lumefantrine ( AL ) plus placebo or AL plus a single or repeated dose ( @ g/kg ) of ivermectin ( AL-IVM@ and AL-IVM@ , respectively ) .